Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar
12 February 2007 - 6:05PM
PR Newswire (US)
EMERYVILLE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
host a conference call on Monday, February 12, 2007, at 10:00 a.m.
Eastern Time (7:00 a.m. Pacific Time) to provide an update on
Nexavar(R) (sorafenib) tablets. Interested parties may access the
live teleconference at: http://audioevent.mshow.com/322954 or by
dialing 706-758-9355 and using the passcode 8490285. A replay of
the teleconference will be available on the Onyx website or by
dialing 706-645-9291 and using the passcode 8490285 approximately
one hour after the teleconference concludes. The replay will be
available through March 12, 2007. Onyx Pharmaceuticals, Inc. is a
biopharmaceutical company developing innovative therapies that
target the molecular mechanisms that cause cancer. The company is
developing Nexavar(R), a small molecule drug, with Bayer
Pharmaceuticals Corporation. Nexavar has been approved for the
treatment of advanced kidney cancer. For more information about
Onyx's pipeline and activities, visit the company's web site at:
http://www.onyx-pharm.com/. Nexavar(R) (sorafenib) tablets is a
registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Julie Wood,
+1-510-597-6505, or Alexandra Santos, +1-510-597-6504, both of Onyx
Pharmaceuticals, Inc. Web site: http://www.onyx-pharm.com/
http://audioevent.mshow.com/322954
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles